Stock Events

Stock Events

Daxor 

€8.2
2
-€0.15-1.8% Today

Statistics

Day High
8.2
Day Low
8.2
52W High
12.6
52W Low
6.2
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
5.88
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jan 18
€0.02
Dec 16
€0.03
Dec 15
€0.04
Dec 14
€0.02
Dec 13
€0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

27FebExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-133.37%Profit Margin
Unprofitable
2010
2011
2016
2017
2018
2019
337,564.58Revenue
-450,205.35Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DX5.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a range of analytical instruments and services that compete with Daxor's blood volume analysis technology.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its subsidiaries, provides products and services in the field of medical diagnostics, competing with Daxor's diagnostic solutions.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company manufactures and sells medical devices, instrument systems, and reagents, offering products that could be used in similar applications as Daxor's.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including diagnostics that compete with Daxor.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the healthcare field, offering a wide range of products and services, including diagnostics and medical devices that could compete with Daxor's offerings.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment and diagnostics tools that could be seen as competitive to Daxor's products.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, potentially competing with Daxor's diagnostic technologies.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc designs, manufactures, and sells device-based medical therapies and services, including those that could compete with Daxor's blood volume analysis products.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on women's health and diagnostic solutions, offering products that could compete in the same market as Daxor's diagnostic technologies.
GE Aerospace
GE
Mkt Cap325.88B
General Electric Company, through its healthcare segment, provides medical imaging, monitoring, biomanufacturing, and cell therapy technology, competing in the broader medical diagnostics and research field alongside Daxor.

About

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Show more...
CEO
Mr. Michael Richard Feldschuh
Country
DE
ISIN
US2394671034
WKN
000871275

Listings

F
DE
DX5.F
XNAS
US
DXR
BOATS
BOATS
DXR.BOATS

0 Comments

Share your thoughts

FAQ

What is Daxor stock price today?▼
The current price of DX5.F is €8.2 EUR — it has decreased by -1.8% in the past 24 hours. Watch Daxor stock price performance more closely on the chart.
What is Daxor stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Daxor stocks are traded under the ticker DX5.F.
Is Daxor stock price growing?▼
DX5.F stock has fallen by -8.89% compared to the previous week, the month change is a -21.15% fall, over the last year Daxor has showed a +12.33% increase.
What is Daxor revenue for the last year?▼
Daxor revenue for the last year amounts to 337,564.58 EUR.
What is Daxor net income for the last year?▼
DX5.F net income for the last year is -450,205.35 EUR.
Does Daxor pay dividends?▼
Yes, DX5.F dividends are paid semi-annual. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Daxor located?▼
Daxor operates in the Health Care sector.
When did Daxor complete a stock split?▼
Daxor has not had any recent stock splits.
Where is Daxor headquartered?▼
Daxor is headquartered in Oak Ridge, DE.